OUR APPROACH
Engineered, not copied.
A virus is not a single, fixed target but a family of related variants that keeps changing. Our platform combines machine learning, structural biology and evolutionary analysis to read how a viral family has evolved, then engineers a new antigen around what its members share.
HOW IT WORKS
How We Engineer Our Antigens
Our platform generates vaccine candidates that preserve the essential genetic and structural characteristics shared across a clade, lineage, or entire viral family
THE AI LAYER
AI-based Computational Platform
From the full sequence history of a viral family to a short list of designed antigens, in silico.
ANTIGEN DESIGN
Engineering The Antigen Backbone
Targeted modifications that turn an evolutionary backbone into the final DVX antigen.
What the modifications are for:
AT A GLANCE
What changes with DIOSynVax
Discover how DIOSynVax’s approach differs from conventional vaccine design. Hover or tap each card to explore.
1
Design input
WHAT MOST VACCINES DO
One circulating viral strain.
↻ Flip for the DIOSynVax approach
1
Design input
WHAT DIOSYNVAX DOES
The evolutionary history of a clade, lineage or family.
WHY IT MATTERS
The antigen represents the family, not one member.
↻ Flip back
2
The antigen
WHAT MOST VACCINES DO
Copies the antigen sequence of that strain.
↻ Flip for the DIOSynVax approach
2
The antigen
WHAT DIOSYNVAX DOES
Engineered: a new backbone carrying conserved, protective epitopes.
WHY IT MATTERS
Immune focus shifts to features shared across the viral family.
↻ Flip back
3
Immune targets
WHAT MOST VACCINES DO
Usually one surface protein, eliciting antibodies to one target.
↻ Flip for the DIOSynVax approach
3
Immune targets
WHAT DIOSYNVAX DOES
Surface and internal proteins are engineered, engaging both humoral and cellular immunity.
WHY IT MATTERS
To escape, the virus must evade several responses at once.
↻ Flip back



